Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Amalia Kimber

Nurse Practitioner, Obstetrics & Gynecology Santa Rosa, CA Nurse Practitioner

NPI 1326344268 CMS profile 11205625

1111 Sonoma Ave Ste 202, Santa Rosa, CA 95405

Open in the dashboard

General payments

$7,143

182 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Amalia Kimber of Santa Rosa, CA is reported in the CMS Open Payments database as having received $7,143 across 182 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner, Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $704 25
2024 General $891 45
2023 General $749 29
2022 General $3,999 41
2021 General $799 42

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amalia Kimber
  • Nurse Practitioner, Obstetrics & Gynecology median
  • Middle half of Nurse Practitioner, Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Amalia Kimber were reported at $704. Among 1,030 Nurse Practitioner, Obstetrics & Gynecology profiles paid that year, the median was $151 and the middle half received between $51 and $371.

Show as a table
Year Amalia Kimber Nurse Practitioner, Obstetrics & Gynecology median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $799 $135 $40–$338 $132
2022 $3,999 $143 $45–$386 $149
2023 $749 $153 $54–$411 $160
2024 $891 $140 $45–$326 $164
2025 $704 $151 $51–$371 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Organon LLC $3,598 22 payments
  2. AbbVie, Inc. $892 33 payments
  3. Mayne Pharma Inc. $728 54 payments
  4. Hologic, LLC $462 10 payments
  5. Astellas Pharma US Inc $311 8 payments
  6. TherapeuticsMD, Inc. $175 11 payments
  7. Biohaven Pharmaceuticals, Inc. $119 5 payments
  8. Myovant Sciences Inc. $111 5 payments
  9. Biogen, Inc. $101 4 payments
  10. Pfizer Inc. $93 4 payments
  11. Other $554 26 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,773 176 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $3,213 4 payments
  3. Education $158 2 payments
Products named General payments · program years 2021–2025
  1. NEXPLANON $3,552 20 payments
  2. MYOSURE TISSUE REMOVAL DEVICE $354 4 payments
  3. ACESSA PROVU SYSTEM $343 4 payments
  4. BOTOX $286 9 payments
  5. ORILISSA $184 9 payments
  6. ANNOVERA $175 11 payments
  7. FLUENT FLUID MANAGEMENT SYSTEM $164 2 payments
  8. NURTEC ODT $164 7 payments
  9. ORIAHNN $163 7 payments
  10. LO LOESTRIN FE $160 8 payments
  11. Other $1,495 69 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

182 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Obstetrics & Gynecology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record